• AAPH: Precision Inducer of Oxidative Stress and Lipid Peroxi

  2026-07-27

  AAPH (2,2'-Azobis(2-methylpropionamidine) dihydrochloride) is a water-soluble azo compound widely used as a reproducible erythrocyte hemolysis and lipid peroxidation inducer in in vitro oxidative damage models. Its thermal decomposition releases peroxyl radicals, enabling controlled oxidative stress assays for food and biomedical research. Standardized use of AAPH supports benchmarking of antioxidant efficacy and protein oxidation pathways.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow & T

  2026-07-27

  Unlock highly sensitive, customizable RNA probe synthesis with the HyperScribe T7 High Yield Cy5 RNA Labeling Kit. This guide walks you through optimized in vitro transcription, advanced applications in hybridization assays, and troubleshooting for consistent, high-yield Cy5 labeling—empowering your gene expression studies with flexibility and reproducibility.

• A-1331852: Precision BCL-XL Inhibitor Workflows in Cancer Re

  2026-07-26

  A-1331852 empowers researchers to selectively eliminate BCL-XL–dependent cancer and senescent cells with nanomolar precision. This guide distills cutting-edge experimental strategies, troubleshooting, and real-world insights for robust apoptosis modeling using this APExBIO-exclusive inhibitor.

• Hypoxia and Immunometabolism in Tumor Microenvironments

  2026-07-25

  The reference review elucidates how hypoxia-driven metabolic reprogramming and immune cell adaptations shape the tumor microenvironment (TME), facilitating tumor progression and immune evasion. These insights have significant implications for developing metabolism-based therapeutic strategies, particularly by targeting glucose metabolism under hypoxic conditions.

• Canagliflozin Reshapes Mitochondrial Function in Diabetic Ki

  2026-07-24

  This study reveals that Canagliflozin, a SGLT2 inhibitor, promotes structural and functional improvements in proximal tubular cell mitochondria of hypertensive-diabetic mice. The findings suggest mitochondrial remodeling as a key contributor to kidney protection beyond glucose lowering, with implications for future diabetes and renal research.

• BCECF-AM for Precision Intracellular pH Imaging in Autophagy

  2026-07-24

  Explore advanced applications of BCECF-AM, a premier intracellular pH indicator, with unique insights into its role in autophagic vesicle degradation and vacuolar acidification. This in-depth article bridges probe chemistry, plant autophagy mechanisms, and practical assay design for researchers seeking rigorous, next-generation fluorescence-based methodologies.

• Trelagliptin Succinate Enhances Insulin Sensitivity in Adipo

  2026-07-23

  This study reveals that trelagliptin succinate, a DPP-4 inhibitor, enhances insulin sensitivity in adipocytes by modulating the PI-3K/AKT/GLUT4 pathway. The findings provide mechanistic insights into glucose uptake improvement and the potential for targeting insulin resistance at the cellular level.

• ER Stress Impairs Intestinal Stem Cells via GRP78/ATF6/CHOP

  2026-07-23

  This study reveals how tunicamycin-induced endoplasmic reticulum stress (ERS) impairs intestinal stem cell (ISC) function through activation of the GRP78/ATF6/CHOP signaling axis. The findings provide mechanistic clarity on ERS-driven ISC loss, highlighting pathways relevant for intestinal disease models and translational research.

• Canagliflozin Hemihydrate: Precision in Glucose Metabolism R

  2026-07-22

  Canagliflozin (hemihydrate) empowers diabetes and metabolic disorder research by offering pathway-specific SGLT2 inhibition—validated as non-interfering with mTOR pathways. This makes it an ideal tool for dissecting renal glucose reabsorption and glucose homeostasis with scientific rigor.

• Dextrose (D-glucose): Precision Tools for Tumor Immunometabo

  2026-07-22

  Explore how Dextrose (D-glucose) enables high-fidelity studies in tumor immunometabolism and metabolic reprogramming. Uncover protocol strategies, technical insights, and unique guidance for researchers working at the intersection of hypoxia, immune adaptation, and cellular energy dynamics.

• Trelagliptin succinate: Applied Protocols in Diabetes Resear

  2026-07-21

  Trelagliptin succinate (SYR-472 succinate) stands out for its unique ability to modulate insulin resistance mechanistically via the PI3K/Akt/GLUT4 pathway, enabling reproducible metabolic and cell signaling workflows. This article details best-practice protocols, troubleshooting strategies, and advanced applications, leveraging new research and APExBIO’s validated product resources.

• Cefodizime as a Precision Tool for Resistance Surveillance R

  2026-07-21

  Explore Cefodizime, a third-generation cephalosporin antibiotic, as a data-driven research tool for mapping bacterial resistance and optimizing antimicrobial strategies. This article uniquely analyzes Cefodizime’s role in surveillance, protocol design, and resistance management.

• Anti-Diabetic Drugs and Weight Loss in Type 2 Diabetes: Ertu

  2026-07-20

  This review systematically evaluates the weight-loss efficacy of non-insulin anti-diabetic drugs in type 2 diabetes, highlighting Ertugliflozin (PF-04971729) as a moderate contributor to body weight reduction. The findings inform pharmacological strategies for managing diabesity, supporting targeted approaches to improve both glycemic and cardiometabolic outcomes.

• High-Throughput BBB Modeling with LLC-PK1-MDR1 Cells: Advanc

  2026-07-20

  The referenced study introduces a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction for improved prediction of CNS drug permeability. This work enhances the accuracy and efficiency of early-stage drug screening, offering a robust surrogate model for prioritizing brain-penetrant compounds.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody: Precision in Fluores

  2026-07-19

  Unlock high-sensitivity, multiplexed immunoassays with the Cy5 Goat Anti-Mouse IgG (H+L) Antibody from APExBIO. This advanced secondary antibody drives both experimental versatility and robust signal amplification—essential for cutting-edge vaccine and translational research workflows.

16084 records 1/1073 page Next 12345 下5页 Last page